Michael Rauch Appointed As New CFO Of Evonik, Christian Kullmann Reappointed As CEO

Evonik Industries has appointed Michael Rauch as its new Chief Financial Officer (CFO) following an extraordinary meeting of its supervisory Board, effective May 1, 2026.

The company also extended the contract of Chief Executive Officer (CEO) Christian Kullmann until 2030.

Rauch is a finance executive. He worked 16 years at Henkel in strategy and finance roles in Germany, Sweden, and China. He has experience in capital markets and holds an MBA. He most recently served as interim chief executive officer at Selecta AG. Earlier, he spent five years at CompuGroup Medical, first as CFO and later as CEO. He also worked as CFO at Douglas for two years. He joins the finance leadership team in Germany. He holds a master’s degree in law (mergers & acquisitions) from the University of Muenster.

Christian Kullmann is the Chairman of the Executive Board of Evonik Industries. He began his career at Deutsche Vermögensberatung AG in Frankfurt from 1994 to 1996, followed by roles at Dresdner Bank between 1996 and 2003, where he worked in the general secretariat and later headed public relations and public affairs. In 2003, he joined RAG Aktiengesellschaft in Essen and led communications and executive Board office functions until 2007. From 2007, he held similar roles at Evonik, becoming chief representative in 2013, joining the executive Board in 2014, and serving as Deputy Chairman from 2016. He became Chairman in 2017. He also serves on the supervisory Board of Borussia Dortmund GmbH & Co. KGaA.